![](/img/cover-not-exists.png)
788 Pretreatment clinical prognostic factors influencing survival in patients with stage III non-small cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy (HFX RT) with or without concurrent chemotherapy (CHT)
B. Jeremic, B. Millicic, A. Dagovic, S. Dagovic, J. Stankovic, J. Aleksandrovic, S. BosnjakovicVolume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90813-5
File:
PDF, 163 KB
english, 2003